ATI Announces Third Quarter 2026 Results

ATI reported Q3 2026 sales of $1.424 billion, up 26% year over year, and adjusted EBITDA of $327.9 million, up 46%, with margin expanding 300 bps to 23.0%; adjusted EBITDA exceeded the high end of guidance by $13 million. The company raised its full-year 2026 adjusted EBITDA outlook by $35 million to $1.190 billion–$1.200 billion, following a $125 million increase last quarter, and raised adjusted EPS guidance to $5.17–$5.23. ATI also repurchased $70 million of shares during the quarter at an average $199.62 per share; aerospace and defense accounted for 69% of sales.

Analysis

The bullish signal is not simply faster growth: earnings power is shifting toward AA&S, where pricing, volume and mix are lifting margins, while HPMC is absorbing manufacturing costs as the new superalloy ramps. That split makes execution—not end-market demand—the key near-term variable. If HPMC yields and throughput improve, further operating leverage is plausible; if the ramp persists, consolidated margin expansion may disappoint despite sales growth.

Cash conversion is the main check on the headline beat. Inventory has absorbed substantial cash year-to-date, and Q3 adjusted free cash flow was modest relative to EBITDA. The full-year cash-flow outlook therefore makes Q4 inventory normalization and shipment-to-cash conversion important catalysts, not merely balance-sheet housekeeping. Buybacks support per-share results but do not resolve working-capital intensity.

Near term, guidance revisions and the Q4 EBITDA range support positive estimate momentum, but the smaller latest raise after a much larger prior-quarter increase suggests the revision cycle could be maturing. Over 1–3 months, track Q4 delivery, HPMC ramp costs, and cash conversion. Over 6–18 months, aerospace engine demand and ATI’s ability to turn capacity investment into profitable shipments are the structural drivers; raw-material volatility, production disruption, or OEM schedule changes could reverse the trend.

Key Decisions for Investors

• Favor ATI long exposure, preferably adding on post-earnings weakness rather than chasing the opening move. The thesis is continued earnings revisions and improving AA&S profitability; reassess if Q4 adjusted EBITDA falls below the $345M–$355M guide range or management flags weaker 2027 demand.
• Treat cash conversion as a required confirmation: monitor Q4 adjusted free cash flow against the $550M–$600M full-year outlook, inventory balances, and working capital as a share of sales. Failure to improve cash generation despite EBITDA growth would weaken the quality-of-earnings case and argue for trimming.
• Do not extrapolate AA&S margin gains across the company. Watch HPMC segment margin and costs tied to the new alloy ramp; sustained deterioration alongside rising sales would falsify the operating-leverage thesis.
• The contrarian risk is that the market prices the guidance raise as a durable margin step-up when part of the improvement may reflect pricing and mix. Avoid an aggressive short absent evidence of weakening orders or guidance; the immediate evidence still favors the long, but the shrinking scale of successive guidance increases raises the bar for further upside surprises.